Imatinib does not impair gonadal function.

  title={Imatinib does not impair gonadal function.},
  author={Charles T. H. Chuah},
  journal={Leukemia research},
  volume={36 3},
The Bcr-Abl tyrosine kinase inhibitor, imatinib, was introduced nto the armamentarium for the treatment of chronic myeloid eukemia (CML) and has revolutionized the management and sigificantly improved the long term prognosis of the disease. Durable linical responses are now achievable in a significant number of hronic phase CML patients and their projected… CONTINUE READING